ARCH Venture Partners X, LLC - 10%+ Owner at Prime Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
PRME on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

ARCH Venture Partners X, LLC - trading volume in the past year for Prime Medicine, Inc.

Holdings reported by ARCH Venture Partners X, LLC for Prime Medicine, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.13M $26.7M $4.35 Aug 1, 2025 By ARCH Venture Fund X, L.P.
Common Stock 6.13M $26.7M $4.35 Aug 1, 2025 By ARCH Venture Fund X Overage, L.P.
Common Stock 6.23M $20.6M $3.30 Aug 1, 2025 By ARCH Venture Fund XII, L.P.

Transactions reported by ARCH Venture Partners X, LLC for Prime Medicine, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.